Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ARNALDO VILLAFRANCA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1205886488
CMS profile
682579
Location
MIAMI, FL

General Payments · PY2019–2025

$1,664.50

  • Reported across 63 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$319.43

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $319.43 14

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $123.25 6
Corcept Therapeutics $46.60 2
Amgen Inc. $44.40 2
Xeris Pharmaceuticals, Inc. $39.42 2
Insulet Corporation $37.42 1
Radius Health, Inc. $28.34 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $396.48 10
PY2020 $171.49 9
PY2021 $167.55 8
PY2022 $263.87 12
PY2023 $70.53 3
PY2024 $275.15 7
PY2025 $319.43 14

Payment records · PY2025 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2025 201920202021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $20.13 03/19/2025 Food and Beverage Undisputed 06/30/2026 1228375936 CMS
Amgen Inc. $24.27 04/02/2025 Food and Beverage Undisputed 06/30/2026 1228375938 CMS
Corcept Therapeutics $15.60 10/22/2025 Food and Beverage Undisputed 06/30/2026 1214206673 CMS
Corcept Therapeutics $31.00 11/06/2025 Food and Beverage Undisputed 06/30/2026 1214206701 CMS
Insulet Corporation $37.42 04/21/2025 Food and Beverage Undisputed 06/30/2026 1207080773 CMS
Novo Nordisk Inc $24.11 02/14/2025 Food and Beverage Undisputed 06/30/2026 1188169702 CMS
Novo Nordisk Inc $19.78 04/04/2025 Food and Beverage Undisputed 06/30/2026 1188175961 CMS
Novo Nordisk Inc $25.00 05/11/2025 Food and Beverage Undisputed 06/30/2026 1188503244 CMS
Novo Nordisk Inc $22.22 09/23/2025 Food and Beverage Undisputed 06/30/2026 1188786481 CMS
Novo Nordisk Inc $18.66 11/04/2025 Food and Beverage Undisputed 06/30/2026 1188201232 CMS
Novo Nordisk Inc $13.48 12/15/2025 Food and Beverage Undisputed 06/30/2026 1188610293 CMS
Radius Health, Inc. $28.34 01/07/2025 Food and Beverage Undisputed 06/30/2026 1249503928 CMS
Xeris Pharmaceuticals, Inc. $16.99 04/01/2025 Food and Beverage Undisputed 06/30/2026 1250149776 CMS
Xeris Pharmaceuticals, Inc. $22.43 08/19/2025 Food and Beverage Undisputed 06/30/2026 1250149778 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.